Small Molecule Therapeutics for Schizophrenia

  • Sylvain Celanire
  • Sonia Poli

Part of the Topics in Medicinal Chemistry book series (TMC, volume 13)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Bart A. Ellenbroek, Andrea M. Cesura
    Pages 1-49
  3. Roderick A. Porter, Lee A. Dawson
    Pages 51-99
  4. José M. Cid, Andrés A. Trabanco, Hilde Lavreysen
    Pages 101-142
  5. Theresa Williams, Marlene A. Jacobson, Mikhail Kalinichev, Jean-Philippe Rocher
    Pages 143-182
  6. Takaaki Sumiyoshi, Takeshi Enomoto
    Pages 183-211
  7. Anatoly Mazurov, Daniel Yohannes
    Pages 213-253
  8. Jamison B. Tuttle, Bethany L. Kormos
    Pages 255-316
  9. Back Matter
    Pages 317-323

About this book


The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.


5HT Receptor Ligands DA Receptor Ligands GLYT1 Inhibitors PDE10/PDE9 Inhibitors mACh Activators mGlu2 Activators mGlu5 Positive Allosteric Modulators nACh Activators

Editors and affiliations

  • Sylvain Celanire
    • 1
  • Sonia Poli
    • 2
  1. 1.ReignerFrance
  2. 2.Addex TherapeuticsGenevaSwitzerland

Bibliographic information